Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft Versus Host Disease in Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00702689
What this trial is testing

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Sclerotic Graft Versus Host DiseaseImatinib Mesylate
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT06283550
What this trial is testing

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Who this might be right for
Chronic Hand Eczema
Innovaderm Research Inc. 82
Not applicableEnrolling By InvitationNCT05876390
What this trial is testing

Impact of Regional Anesthesia on Chronic Post-operative Pain

Who this might be right for
Breast Cancer
Niguarda Hospital 1,500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767864
What this trial is testing

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Oregon Health and Science University 15
Large-scale testing (Phase 3)Study completedNCT02077192
What this trial is testing

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals 123
Testing effectiveness (Phase 2)Study completedNCT00371371
What this trial is testing

Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)

Who this might be right for
Peripheral Vascular DiseasesArterial Occlusive DiseasesLeg Ulcer+2 more
UMC Utrecht 160
Not applicableStudy completedNCT01237392
What this trial is testing

Ultrasonic Wound Debridement vs. Standard Sharp Debridement

Who this might be right for
Chronic Skin Ulcers
Calvary Hospital, Bronx, NY 75
Not applicableStudy completedNCT06063044
What this trial is testing

Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children

Who this might be right for
Rhinitis, AllergicAsthma, AllergicConjunctivitis, Allergic+2 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 407
Not applicableLooking for participantsNCT06940986
What this trial is testing

The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

Who this might be right for
Chronic PainMusculoskeletal PainMusculoskeletal Pain Disorder
Brooke Army Medical Center 608
Large-scale testing (Phase 3)Study completedNCT02055118
What this trial is testing

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Who this might be right for
Hunter Syndrome
Shire 58
Post-approval studies (Phase 4)Study completedNCT01012713
What this trial is testing

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
University of California, San Francisco 30
Post-approval studies (Phase 4)Study completedNCT02452918
What this trial is testing

Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
The Medicines Company 17
Testing effectiveness (Phase 2)Study completedNCT02629419
What this trial is testing

CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis

Who this might be right for
Candidiasis, Chronic Mucocutaneous
Matinas BioPharma Nanotechnologies, Inc. 4
Post-approval studies (Phase 4)Looking for participantsNCT07364630
What this trial is testing

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Who this might be right for
Diabetic Foot UlcerFoot Ulcer ChronicDFU+6 more
BioLab Holdings 50
Large-scale testing (Phase 3)Study completedNCT01105507
What this trial is testing

The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada

Who this might be right for
Cryopyrin Associated Periodic Syndrome
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Study completedNCT05443685
What this trial is testing

ADX-629 Therapy for Sjogren-Larsson Syndrome

Who this might be right for
Sjogren-Larsson Syndrome
University of Nebraska 8
Not applicableStudy completedNCT05622578
What this trial is testing

Phenotyping of Chronic Pain in Diffused Systemic Scleroderma

Who this might be right for
Scleroderma, SystemicScleroderma, Diffuse
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Study completedNCT00102739
What this trial is testing

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 99
Large-scale testing (Phase 3)UnknownNCT01359345
What this trial is testing

Nephrogenic Systemic Fibrosis With Gadollinum

Who this might be right for
Nephrogenic Systemic FibrosisRenal Failure
Imam Khomeini Hospital 200
Post-approval studies (Phase 4)Study completedNCT02690701
What this trial is testing

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 91
Next Page